Detalhe da pesquisa
1.
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels.
BMC Cancer
; 19(1): 487, 2019 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31122212